268 results found for 'Visiting hours'

RMH@Home Acute RMH Service

We deliver acute hospital-level treatment and care in the comfort of a person's own home.

https://www.thermh.org.au/services/community-services/rmh-at-home

Cardiology RMH Service

The RMH Cardiology service is located at the RMH Parkville. Find out more about the Cardiology contact and location details.

https://www.thermh.org.au/services/cardiology

How ICU works

We have a dedicated team of specialist doctors, nurses, allied health professionals and support staff, available 24 hours a day.

https://www.thermh.org.au/services/intensive-care/learn-about/how-icu-works

New treatment for moderate-to-severe plaque psoriasis Research study

Treatments that are highly selective in inhibiting the body's immune response have the potential to increase quality of life for people with plaque psoriasis.

https://www.thermh.org.au/research/clinical-trials-research-studies/evaluating-the-efficacy-safety-and-tolerability-of-a-new-treatment-for-people-with-moderate-to-severe-plaque-psoriasis

Our archives

The Archives of the Royal Melbourne Hospital document the traditions and history of the oldest public hospital in Victoria.

https://www.thermh.org.au/about/about-the-rmh/our-history-and-archives/our-archives

Ritlecitinib in adults with non-segmental vitiligo Research study

This trial is investigating a medication for treating people living with non-segmental vitiligo.

https://www.thermh.org.au/research/clinical-trials-research-studies/new-treatment-for-vitiligo

Up, up and away…mobile brain scans to transform urgent stroke care News article

Work is underway to create world-first light, portable brain scanners so more Australians have rapid access to real-time stroke treatment.

https://www.thermh.org.au/news/up-up-and-awaymobile-brain-scans-to-transform-urgent-stroke-care

Remibrutinib for chronic spontaneous urticaria Research study

A clinical trial to assess a new drug for chronic spontaneous urticaria (CSU) not controlled with antihistamine medication or omalizumab (Xolair®) in the past.

https://www.thermh.org.au/research/clinical-trials-research-studies/remibrutinib-for-chronic-spontaneous-urticaria

Media information

Information about how to visit the Royal Melbourne Hospital as a media representative, enquire about patient condition updates, request interviews, plus media on-call hours and more.

https://www.thermh.org.au/news/media-hub/media-information
1 2 3 4 5 6 7